Skip to main content
Premium Trial:

Request an Annual Quote

Jury Says Stratagene Willfully Infringed Third Wave s Patents, Awards $5.3M in Damages

NEW YORK, Sept. 7 (GenomeWeb News) - A jury has found that Stratagene has willfully infringed two nucleic acid testing patents held by Third Wave Technologies, and has awarded Third Wave $5.3 million in damages, Third Wave said yesterday.


Last week, the jury determined that Stratagene's FullVelocity quantitative PCR and RT-PCR products infringe the two patents.


Third Wave said it will seek additional damages based on the willfulness of the infringement of the patents, which are the basis for its Invader nucleic acid-testing chemistry. The company also seeks a permanent injunction and destruction of Stratagene's infringing FullVelocity reagents.


Stratagene said on Monday that it will appeal the jury's verdict.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.